JohnREckardtMD
Oncology • Saint Louis, MOHematologic Oncology, Thoracic Cancer
Chief Medical Officer DAVA Oncology
Dr. Eckardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12855 N 40 Dr
Ste 200
Saint Louis, MO 63141Phone+1 314-628-1210Fax+1 314-628-1220
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1990 - 1993
Mercy Hospital (St Louis)Residency, Internal Medicine, 1987 - 1990
Saint Louis University School of MedicineClass of 1987
Certifications & Licensure
MO State Medical License 1988 - 2026
Clinical Trials
- Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer Start of enrollment: 2008 Feb 22
- Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2008 Jul 01
- Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer Start of enrollment: 2008 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 49 citationsPhase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS)Amanda F. Cashen, Mark B. Juckett, Alcee Jumonville, Mark R. Litzow, Patrick J. Flynn
Annals of Hematology. 2012-01-01 - 10 citationsSafety and resource utilization by non-small cell lung cancer histology: results from the randomized phase III study of pemetrexed plus cisplatin versus gemcitabine pl...Silvia Novello, Francisco Luís Pimentel, Jean-Yves Douillard, Mary O'Brien, Joachim von Pawel
Journal of Thoracic Oncology. 2010-10-01 - 29 citationsA study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: A phase 2 consortium studyGary A. Croghan, Vera J. Suman, William J. Maples, Mark R. Albertini, Gerald P. Linette
Cancer. 2010-07-15
Grant Support
- Phase I Of Ly309887 In Patients With Metastatic CancerNational Center For Research Resources1996–1997
- Phase I Of BCNU And TemozolomideNational Center For Research Resources1996–1997
- Phase I Of SCH 52365 In Patients With Advanced CancerNational Center For Research Resources1996
- Study Comparing Stanozolol And Placebo In Patients With Cancer CachexiaNational Center For Research Resources1993–1996
- Phase I Trial--Escalating Doses Of Continuous Infusion Of Topotecan &EtoposideNational Center For Research Resources1993–1996
- Phase I Trial Of Rp60475 Administered As A 1/2 Hour Infusion Every 21 DaysNational Center For Research Resources1993–1994
- Phase I Study Of Toremifene And Doxorubicin In Patients With Advanced CancerNational Center For Research Resources1993–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
